Tumour-specific loss of heterozygosity within the chromosomal region harboring PRKAR1A is observed in tumours from CNC patients and isolated PPNAD, suggesting that PRKAR1A is a potential tumour suppressor gene [4]. The gene discussed is PRKAR1A; the disease is primary pigmented nodular adrenocortical disease.